Skip to main content
NVDA+0.96%AAPL-0.06%GOOGL+0.86%MSFT+0.92%AMZN+0.87%TSM+2.75%SPCX+7.63%META+0.24%AVGO+2.08%TSLA+0.81%SKHY-0.06%MU+0.28%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.50%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.04%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.71%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.81%USDZAR-0.71%USDMXN-0.70%AUDCHF+0.68%USDPLN-0.68%AUDJPY+0.58%USDSEK-0.50%CHFSEK-0.50%GBPCHF+0.48%GBPTRY+0.41%NZDMXN-0.40%GBPJPY+0.40%NOKJPY+0.37%EURZAR-0.36%AUDUSD+0.36%EURHKD+0.35%EURPLN-0.34%AUDNZD+0.33%GBPZAR-0.33%USDDKK-0.33%GBPHKD+0.32%EURAUD-0.31%EURCNH+0.31%AUDCAD+0.30%CADCHF+0.29%GBPMXN-0.28%EURCHF+0.28%NZDCHF+0.27%USDNOK-0.25%SGDJPY+0.25%USDCHF+0.25%CHFNOK-0.24%GBPSGD+0.24%GBPUSD+0.23%CADJPY+0.22%GBPNZD+0.21%NZDJPY+0.21%EURSGD+0.20%EURJPY+0.20%AUDDKK-0.20%USDJPY+0.19%GBPCAD+0.19%EURGBP-0.18%NZDSGD+0.17%EURCZK-0.16%EURSEK-0.16%USDILS+0.16%GBPAUD-0.16%USDTHB+0.14%USDSGD-0.13%CHFSGD-0.13%AUDNOK-0.12%USDTRY+0.11%EURNOK+0.09%CHFJPY-0.08%EURUSD+0.05%USDCAD-0.05%USDCOP-0.04%EURNZD+0.03%USDCNH-0.03%NZDUSD+0.02%NZDCAD-0.02%EURDKK+0.01%USDHKD+0.01%EURCAD-0.01%AUDSGD0.00%UKOIL-2.76%USOIL-2.00%COCOA-1.91%XPTUSD-1.15%XAUUSD+0.69%GAUUSD+0.69%XNGUSD+0.66%GAGUSD+0.35%XAGUSD+0.35%COTTON+0.20%SUGAR-0.19%HG1-0.15%BTCUSD+0.58%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.24%ZECUSDT+2.71%DOGEUSD-1.82%XMRUSDT-0.11%LINKUSD+3.21%XLMUSD+0.14%BCHUSDT+0.07%UNIUSD-2.16%LTCUSD-4.60%SUIUSD-1.45%HBARUSDT-0.89%TONUSD+12.52%TAOUSDT-0.78%AAVEUSD+0.46%DOTUSDT-1.19%ICPUSDT-4.42%ONDOUSDT-0.26%WLDUSDT+1.36%ARBUSDT-3.45%JUPUSDT-1.29%ATOMUSDT-0.97%INJUSDT+1.87%STXUSDT+0.08%FETUSDT-1.74%SEIUSDT-0.61%PYTHUSDT+1.33%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-0.99%OPUSDT-3.71%IOTAUSDT+3.64%WIFUSDT0.00%AXSUSDT-1.40%POLUSDT-0.36%FARTCOINUSDT+1.90%EOSUSDT+5.86%DYDXUSDT-2.61%GALAUSDT-0.92%ORDIUSDT+1.87%RONINUSDT+2.94%NOTUSDT+1.29%NVDA+0.96%AAPL-0.06%GOOGL+0.86%MSFT+0.92%AMZN+0.87%TSM+2.75%SPCX+7.63%META+0.24%AVGO+2.08%TSLA+0.81%SKHY-0.06%MU+0.28%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.50%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.04%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.71%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.81%USDZAR-0.71%USDMXN-0.70%AUDCHF+0.68%USDPLN-0.68%AUDJPY+0.58%USDSEK-0.50%CHFSEK-0.50%GBPCHF+0.48%GBPTRY+0.41%NZDMXN-0.40%GBPJPY+0.40%NOKJPY+0.37%EURZAR-0.36%AUDUSD+0.36%EURHKD+0.35%EURPLN-0.34%AUDNZD+0.33%GBPZAR-0.33%USDDKK-0.33%GBPHKD+0.32%EURAUD-0.31%EURCNH+0.31%AUDCAD+0.30%CADCHF+0.29%GBPMXN-0.28%EURCHF+0.28%NZDCHF+0.27%USDNOK-0.25%SGDJPY+0.25%USDCHF+0.25%CHFNOK-0.24%GBPSGD+0.24%GBPUSD+0.23%CADJPY+0.22%GBPNZD+0.21%NZDJPY+0.21%EURSGD+0.20%EURJPY+0.20%AUDDKK-0.20%USDJPY+0.19%GBPCAD+0.19%EURGBP-0.18%NZDSGD+0.17%EURCZK-0.16%EURSEK-0.16%USDILS+0.16%GBPAUD-0.16%USDTHB+0.14%USDSGD-0.13%CHFSGD-0.13%AUDNOK-0.12%USDTRY+0.11%EURNOK+0.09%CHFJPY-0.08%EURUSD+0.05%USDCAD-0.05%USDCOP-0.04%EURNZD+0.03%USDCNH-0.03%NZDUSD+0.02%NZDCAD-0.02%EURDKK+0.01%USDHKD+0.01%EURCAD-0.01%AUDSGD0.00%UKOIL-2.76%USOIL-2.00%COCOA-1.91%XPTUSD-1.15%XAUUSD+0.69%GAUUSD+0.69%XNGUSD+0.66%GAGUSD+0.35%XAGUSD+0.35%COTTON+0.20%SUGAR-0.19%HG1-0.15%BTCUSD+0.58%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.24%ZECUSDT+2.71%DOGEUSD-1.82%XMRUSDT-0.11%LINKUSD+3.21%XLMUSD+0.14%BCHUSDT+0.07%UNIUSD-2.16%LTCUSD-4.60%SUIUSD-1.45%HBARUSDT-0.89%TONUSD+12.52%TAOUSDT-0.78%AAVEUSD+0.46%DOTUSDT-1.19%ICPUSDT-4.42%ONDOUSDT-0.26%WLDUSDT+1.36%ARBUSDT-3.45%JUPUSDT-1.29%ATOMUSDT-0.97%INJUSDT+1.87%STXUSDT+0.08%FETUSDT-1.74%SEIUSDT-0.61%PYTHUSDT+1.33%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-0.99%OPUSDT-3.71%IOTAUSDT+3.64%WIFUSDT0.00%AXSUSDT-1.40%POLUSDT-0.36%FARTCOINUSDT+1.90%EOSUSDT+5.86%DYDXUSDT-2.61%GALAUSDT-0.92%ORDIUSDT+1.87%RONINUSDT+2.94%NOTUSDT+1.29%
BL

Bio-Rad Laboratories, Inc. (BIO)

NYSE • Healthcare

$379.82
+$10.68 (+2.9%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$368.07
Day Range$363.96 - $381.78
Avg. Volume (3M)281K
Market Cap$10.2B
P/E Ratio45.6
52 Week Range
$236.73$396.23
Next EarningsIn 29 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$651M100%
Gross Profitminus cost of goods$345.8M53%
Operating Incomeminus R&D and overhead$72.6M11%
Net Incomeminus taxes and the rest$371.4M57%

In plain terms: out of every $100 in revenue, Bio-Rad Laboratories, Inc. keeps $57 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.5B
Net Income (TTM)
$222.4M
EPS (TTM)
$8.33
ROA (TTM)
2.17%
Current Ratio
3.14
Dividend Yield
0.2%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-2.3%Q1 2026$2.51
-4.1%Q2 2026$1.89
+49.7%Q3 2026$2.62
Next

Nov 4

in 29 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +49.7%

Bio-Rad Laboratories beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 4, with adjusted EPS of $2.62 topping the $1.75 estimate by about +49.7% and revenue of about $651.0 million exceeding the $624.0 million consensus by +4.3%. Revenue slipped 0.1% from $651.6 million a year ago, while adjusted EPS edged up 0.4% from $2.61. Gross profit came to about $345.8 million, leaving gross margin near 53%, and operating income was about $72.6 million with operating margin around 11%. Operating cash flow reached $98.7 million; Bio-Rad also repurchased $31.5 million of stock and paid $15.7 million in dividends. Consensus for the next period calls for EPS of $2.38 on revenue of $651.1 million.

Next report — what to expect

Bio-Rad Laboratories, Inc. (BIO) reports on November 4, 2026. Wall Street expects EPS of $2.23 on revenue of $649.9 million. As trailing context, revenue was -0.1% year over year last quarter. BIO has beaten EPS in 5 of 8 most recent quarters, so focus will be on results versus these expectations.

View full earnings history

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops and sells life-science and clinical diagnostics products on the NYSE under BIO, operating in healthcare as a maker of laboratory and diagnostic systems. Across its two businesses, the company generated $2.6 billion of revenue in FY2025.

Name
Bio-Rad Laboratories, Inc.
CEO
Norman D. Schwartz
Website
www.bio-rad.com
Industry
Healthcare
Year Founded
1952
Employees
7,450

Today's Snapshot

AI-generated

Yesterday BIO rose 2.9% to 379.82.

Trading Volume

Above 10d avg 271.0K

279.3K

vs S&P 500 Today

Outperforming Market

+2.23%

Updated: October 6, 2026 at 12:17 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
BioMarin is displaying broad technical strength with price trading above short-, medium- and long-term moving averages and the pivot, supported by positive momentum and a modestly positive MACD. Trend strength reads constructive with ADX in the low 30s, while on-balance volume shows accumulation and ATR indicates moderate volatility consistent with an established uptrend. Oscillators are neutral-to-favorable, so gains appear backed by trend and volume rather than extreme momentum. Overall, the indicators align toward renewed upside bias. Technical takeaway: Strong Buy — trend and volume support the bullish case.
All signals
  • EMA (5 indicators)$324.22 - $375.29
    Buy
  • RSI (14)54.03
    Neutral
  • Stochastic %K (14, 3, 3)41.23
    Neutral
  • MACD Level (12, 26)1.53
    Neutral

Peers & Related Assets

CRLCharles River Laboratories International, Inc.
$310.77+7.1%
PENPenumbra, Inc.
$317.11-0.1%
DVADaVita Inc.
$178.72+0.0%
GMEDGlobus Medical, Inc.
$76.57+1.3%
ALGNAlign Technology, Inc.
$140.65-2.1%
HSICHenry Schein, Inc.
$84.23-0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.